Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report kdunleavy Thu, 03/31/2022 – 09:49 More: Feds probe ring of counterfeit HIV meds targeting Gilead, GlaxoSmithKline and Johnson & Johnson: report Source: fierce
read moreTargeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win aliu Thu, 03/31/2022 – 09:24 More: Targeting GSK and AstraZeneca, Clovis lifts sinking Rubraca with broad ovarian cancer win Source: fierce
read moreBayer sheds some sites in €2B push to expand next-gen manufacturing capabilities jkeenan Thu, 03/31/2022 – 08:16 More: Bayer sheds some sites in €2B push to expand next-gen manufacturing capabilities Source: fierce
read moreIn phase 2 trials, the drug reduced ‘OFF time’ which refers to periods of the day when Parkinson’s symptoms recur despite medication More: Positive results for Cerevance’s Parkinson’s drug Source: News
read moreMTX652 has advanced through preclinical regulatory toxicology studies and is ready for a phase 1 trial More: Mission Therapeutics launches clinical trial for kidney disease therapy Source: News
read moreNovavax, hoping to bump up its lagging European launch, asks EMA to authorize its COVID shot in teenagers badams Thu, 03/31/2022 – 07:13 More: Novavax, hoping to bump up its lagging European launch, asks EMA to authorize its COVID shot
read more© 1994 - 2023 B.M. Pharmaceuticals